IRIS Accounts Production v25.4.0.155 07080325 Board of Directors 1.4.24 31.3.25 31.3.25 false true false false false true false 688899 688899 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh070803252024-03-31070803252025-03-31070803252024-04-012025-03-31070803252023-03-31070803252023-04-012024-03-31070803252024-03-3107080325ns15:EnglandWales2024-04-012025-03-3107080325ns14:PoundSterling2024-04-012025-03-3107080325ns10:Director12024-04-012025-03-3107080325ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3107080325ns10:SmallEntities2024-04-012025-03-3107080325ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3107080325ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3107080325ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3107080325ns10:FullAccounts2024-04-012025-03-310708032512024-04-012025-03-310708032542ns10:Director22023-03-310708032542ns10:Director22023-04-012024-03-3107080325ns10:Director22024-04-012025-03-3107080325ns10:CompanySecretary12024-04-012025-03-3107080325ns10:RegisteredOffice2024-04-012025-03-3107080325ns5:CurrentFinancialInstruments2025-03-3107080325ns5:CurrentFinancialInstruments2024-03-3107080325ns5:ShareCapital2025-03-3107080325ns5:ShareCapital2024-03-3107080325ns5:RetainedEarningsAccumulatedLosses2025-03-3107080325ns5:RetainedEarningsAccumulatedLosses2024-03-3107080325ns5:NetGoodwill2024-04-012025-03-3107080325ns5:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3107080325ns5:PlantMachinery2024-04-012025-03-3107080325ns5:NetGoodwill2024-03-3107080325ns5:NetGoodwill2025-03-3107080325ns5:NetGoodwill2024-03-3107080325ns5:PlantMachinery2024-03-3107080325ns5:PlantMachinery2025-03-3107080325ns5:PlantMachinery2024-03-3107080325ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3107080325ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3107080325ns10:Director112024-03-3107080325ns10:Director112023-03-3107080325ns10:Director112024-04-012025-03-3107080325ns10:Director112023-04-012024-03-3107080325ns10:Director112025-03-3107080325ns10:Director112024-03-31
REGISTERED NUMBER: 07080325 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

FOR

A.P.C. (PATHOLOGY) LIMITED

A.P.C. (PATHOLOGY) LIMITED (REGISTERED NUMBER: 07080325)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


A.P.C. (PATHOLOGY) LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2025







DIRECTORS: Dr R L Attanoos
Mrs E L Attanoos





SECRETARY: Mrs E L Attanoos





REGISTERED OFFICE: Boverton Park House
Boverton Park Drive
Boverton
Vale of Glamorgan
CF61 1UH





REGISTERED NUMBER: 07080325 (England and Wales)





ACCOUNTANTS: Xeinadin South Wales and West Limited
Court House
Court Road
Bridgend
CF31 1BE

A.P.C. (PATHOLOGY) LIMITED (REGISTERED NUMBER: 07080325)

BALANCE SHEET
31 MARCH 2025

2025 2024
Notes £ £ £ £
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 7,145 6,207
7,145 6,207

CURRENT ASSETS
Debtors 6 1,372,250 1,646,095
Investments 7 10,243,524 9,044,374
Cash at bank 1,348,227 1,765,878
12,964,001 12,456,347
CREDITORS
Amounts falling due within one year 8 563,489 1,092,244
NET CURRENT ASSETS 12,400,512 11,364,103
TOTAL ASSETS LESS CURRENT
LIABILITIES

12,407,657

11,370,310

PROVISIONS FOR LIABILITIES 218,276 277,340
NET ASSETS 12,189,381 11,092,970

CAPITAL AND RESERVES
Called up share capital 5 5
Retained earnings 9 12,189,376 11,092,965
12,189,381 11,092,970

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

A.P.C. (PATHOLOGY) LIMITED (REGISTERED NUMBER: 07080325)

BALANCE SHEET - continued
31 MARCH 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 9 December 2025 and were signed on its behalf by:





Dr R L Attanoos - Director


A.P.C. (PATHOLOGY) LIMITED (REGISTERED NUMBER: 07080325)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025


1. STATUTORY INFORMATION

A.P.C. (Pathology) Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2010, is being amortised evenly over its estimated useful life of nil years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

A.P.C. (PATHOLOGY) LIMITED (REGISTERED NUMBER: 07080325)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Current asset investments
Current asset investments are initially recognised at cost and are subsequently revalued to their fair value at the balance sheet date with any gains or losses on revaluation being recognised in the income statement for the year.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2024 - 3 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£
COST
At 1 April 2024
and 31 March 2025 300,000
AMORTISATION
At 1 April 2024
and 31 March 2025 300,000
NET BOOK VALUE
At 31 March 2025 -
At 31 March 2024 -

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£
COST
At 1 April 2024 28,599
Additions 2,939
At 31 March 2025 31,538
DEPRECIATION
At 1 April 2024 22,392
Charge for year 2,001
At 31 March 2025 24,393
NET BOOK VALUE
At 31 March 2025 7,145
At 31 March 2024 6,207

A.P.C. (PATHOLOGY) LIMITED (REGISTERED NUMBER: 07080325)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£ £
Trade debtors 1,372,250 1,646,095

7. CURRENT ASSET INVESTMENTS
2025 2024
£ £
7iM Investments 5,047,197 5,584,293
Natwest investment - 2,049,500
Brewin Dolphin Investment 5,196,327 1,410,581
10,243,524 9,044,374

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£ £
Taxation and social security 467,399 1,082,004
Other creditors 96,090 10,240
563,489 1,092,244

9. RESERVES

Included in reserves are unrealised gains on investments of £1,139,462 (2024: £1,451,514).

10. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 March 2025 and 31 March 2024:

2025 2024
£ £
Dr R L Attanoos and Mrs E L Attanoos
Balance outstanding at start of year - 688,899
Amounts repaid - (688,899 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year - -

11. RELATED PARTY DISCLOSURES

Included in creditors is an amount due to the directors of £96,091 (2024: £6,371).